- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05367791
Improving Postural Control Through Innovative Stimulation of the Proprioceptive System (IMPULSES)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is particularly important when considering populations with impaired proprioception resulting in impaired posture and gait control. This is particularly the case for older adults and children with cerebral palsy (CP). Nevertheless, drastic differences exist between the two populations in the nature of these alterations: stable (children with CP) vs. progressive (older adults); brain lesion/upper motor neuron (children with CP) vs. processing deficits and peripheral sensory degradation (older adults); growing (children with CP) vs. fully developed individuals (older adults). However, both populations can improve their postural control with postural exercise programmes. In humans, the proprioceptive system can also be stimulated non-invasively by mechanical vibrations applied to tendons or muscles (localised vibration; LV), or by electrical stimulation of peripheral nerves (somatosensory electrical stimulation; SES). As a result, chronically applied SES can improve sensorimotor function in healthy adults and some clinical cohorts. Similarly, a 6-week weight-bearing and weight-shifting training programme combined with LV has been reported to provide improved benefits in postural control, again in stroke patients.The greater improvement in motor function when LV or SES is added to active muscles may reflect an adjuvant effect: the sensory signal from LV or SES stimulation is integrated with the sensory signals from the task being performed, thus acting as an associative conditioning of the proprioceptive system, and leading to improved sensorimotor integration. The present project aims to study the effectiveness of a short-term intervention combining postural exercises with LV, SES, or the combination of both.
In particular, this study will focus on the effects of these interventions on proprioception, postural control and walking in children with CP and older adults.Confirmation of hypotheses will open up new avenues for rehabilitation therapies and preventive interventions, and may be extended to other purposes and clinical populations.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Saint-Étienne, France, 42055
- CENTRE HOSPITALIER DE SAINT-ETIENNE
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Older Adults:
- Affiliated or beneficiaries of a social security plan
- Who have freely given their written consent after having been informed of the purpose, the procedure and the potential risks involved
Children with Cerebral Palsy:
- Children between the ages of 7 and 18 years, diagnosed with Spastic Cerebral Palsy, presenting with a clinical picture of infantile cerebral hemiplegia or diplegia.
- Children able to understand and follow the simple instructions of the examination
- Children walking GMFCS (Gross Motor Functional Classification system) I to II.
- Children with at least one parent and the child having given and signed the consent agreement
- Children who are members or beneficiaries of a social security system
Exclusion Criteria:
Older adults:
- Pathology or surgery resulting in a locomotor disorder, within 6 months prior to the study,
- Chronic neurological, motor or psychological pathologies
- Use of neuro-active substances likely to alter cortico-spinal excitability (hypnotics, anti-epileptics, psychotropic drugs, muscle relaxants) during the study.
Contraindication to transcranial magnetic stimulation:
- Cardiac or respiratory insufficiency.
- Wearing a cardiac pace maker.
- Wearing a heart valve and severe cardiovascular diseases.
- Presence of prosthetic material or ferromagnetic foreign bodies in the head.
- Presence of cochlear implants or ocular prosthetic material.
- History of neurosurgical procedures.
- Neurological diseases that may affect brain structures and cognitive abilities (e.g., intracranial tumor, multiple sclerosis, history of stroke or head injury).
- Participation at the same time in another interventional trial or having participated in a such a study within 30 days prior to this study.
- Obesity (body mass index ≥ 30.0 kg/m²)
Children with cerebral palsy:
- Children with concomitant muscle disease (e.g., myopathy...).
- Children who have received a baclofen injection in the 6 months preceding the evaluation.
- Children who have undergone neuro-orthopedic surgery on the lower limbs within the last 6 months
- Children who have received a botulinum toxin injection within the last 6 months
- Children participating in therapeutic programs other than their usual physical therapy sessions.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: POSTUR
Postural training only.
|
Training sessions without any stimulation
|
|
Other: POSTUR + LV (localized vibration)
Postural training combined with localized vibration
|
Training sessions without any stimulation
Training sessions with localized vibration
|
|
Other: POSTUR+SES (somatosensory electrical stimulation)
Postural training combined with somatosensory electrical stimulation
|
Training sessions without any stimulation
Training sessions with somatosensory electrical stimulation
|
|
Other: POSTUR+LV-SES
Postural training combined with somatosensory electrical stimulation and localized vibration
|
Training sessions without any stimulation
Training sessions with localized vibration
Training sessions with somatosensory electrical stimulation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of body balance with the Berg Balance Scale (BBS)
Time Frame: Change from Week 8 to Week 16
|
Variation of postural control
|
Change from Week 8 to Week 16
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of body balance with the Berg Balance Scale (BBS)
Time Frame: Change from Week 1 to Week 22
|
Variation of postural control
|
Change from Week 1 to Week 22
|
|
Evaluation of the displacement of the center of pressure with force platform in centimeter
Time Frame: Change from Week 1 to Week 22
|
Variation of postural control
|
Change from Week 1 to Week 22
|
|
Displacement of the centrer of pressure with application of localized vibration in centimeter
Time Frame: Change from Week 1 to Week 22
|
Proprioceptive contribution to postural control
|
Change from Week 1 to Week 22
|
|
Measure of the angular position error in degrees
Time Frame: Change from Week 1 to Week 22
|
Variation of the position direction
|
Change from Week 1 to Week 22
|
|
Coefficient of variation muscle force control in percent
Time Frame: Change from Week 1 to Week 22
|
Muscle force control measurement
|
Change from Week 1 to Week 22
|
|
Measure 6-minute walk test (6MWT) in meters
Time Frame: Change from Week 1 to Week 22
|
Walking ability evaluation
|
Change from Week 1 to Week 22
|
|
Measure Timed Up & Go Test (TUG) in seconds
Time Frame: Change from Week 1 to Week 22
|
Walking ability evaluation
|
Change from Week 1 to Week 22
|
|
Measure 10 meter walk test (10MWT) in seconds
Time Frame: Change from Week 1 to Week 22
|
Walking ability evaluation
|
Change from Week 1 to Week 22
|
|
Quantifying corticospinal excitability with motor evoked potentials in milliVolt
Time Frame: Change from Week 1 to Week 22
|
Underlying neural adaptations evaluation in older adults only
|
Change from Week 1 to Week 22
|
|
Quantifying spinal excitability with H-reflex in milliVolt
Time Frame: Change from Week 1 to Week 22
|
Underlying neural adaptations evaluation in older adults only
|
Change from Week 1 to Week 22
|
Collaborators and Investigators
Investigators
- Principal Investigator: Léonard FEASSON, PHD, CHU de Saint-Etienne
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 21CH160
- 2021-A02416-35 (Other Identifier: ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sensorimotor Disorder
-
University of ÉvoraCompletedTraining | Sensorimotor DisorderPortugal
-
Pamukkale UniversityCompletedWhole-body Vibration | Chronic Non-specific Neck Pain | Sensorimotor Function | Sensorimotor ExerciseTurkey (Türkiye)
-
Kirsehir Ahi Evran UniversitesiCompleted
-
Swiss Federal Institute of TechnologyBalgrist University HospitalCompletedGait Disorder, SensorimotorSwitzerland
-
Central Institute of Mental Health, MannheimCompletedNeuroplasticity | SensorimotorGermany
-
Ludwig-Maximilians - University of MunichCompletedSensorimotor Gait DisorderGermany
-
Assistance Publique - Hôpitaux de ParisRecruitingComplex Sensorimotor DisabilitiesFrance
-
Hangang Sacred Heart HospitalNot yet recruiting
-
Hangang Sacred Heart HospitalMinistry of Health, Republic of KoreaCompletedBurns | Gait Disorder, SensorimotorKorea, Republic of